GEN-PROBE INCORPORATED 
By BEDFORD, Mass., Oct. 24, 2013/PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced plans to release its fourth quarter fiscal 2013 operating results on Monday, November 11, 2013, after market close. In conjunction with the release, management will host a conference call on Monday, November 11, 2013, at 5:00 p.m.(Eastern).
Interested participants may listen to the call by dialing 877-681-3377 or 719-325-4898 for international callers and referencing participant code 2897258 approximately 15 minutes prior to the call on November 11th. For those unable to participate in the live broadcast, a replay will be available two hours after the call ends through Friday, November 29, 2013, at 888-203-1112 or 719-457-0820 for international callers, access code 2897258.
The Company will also provide a live webcast of the call. Interested participants may access the webcast on the Company's website at www.hologic.com/investors-overview. A replay of the call will be archived on the Company's website and a PowerPoint presentation related to the conference call will be posted to the site after market close on Monday, November 11, 2013.
About Hologic, Inc.:
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives.Massachusetts. For more information, visit www.hologic.com.
